Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1969 1
1970 4
1971 4
1972 3
1973 1
1974 2
1975 4
1976 5
1977 5
1978 2
1979 4
1980 6
1981 6
1982 10
1983 13
1984 12
1985 8
1986 11
1987 8
1988 5
1989 12
1990 15
1991 9
1992 9
1993 12
1994 14
1995 17
1996 8
1997 10
1998 11
1999 14
2000 21
2001 15
2002 22
2003 27
2004 21
2005 31
2006 26
2007 23
2008 24
2009 44
2010 25
2011 29
2012 41
2013 49
2014 53
2015 56
2016 75
2017 68
2018 61
2019 65
2020 65
2021 86
2022 76
2023 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,135 results

Results by year

Filters applied: . Clear all
Page 1
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, D'Arcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L. Trigo J, et al. Among authors: sala ma. Lancet Oncol. 2020 May;21(5):645-654. doi: 10.1016/S1470-2045(20)30068-1. Epub 2020 Mar 27. Lancet Oncol. 2020. PMID: 32224306 Clinical Trial.
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.
Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA; Northwestern Comprehensive COVID Center Consortium. Mylvaganam RJ, et al. Among authors: sala ma. Eur Respir Rev. 2021 Dec 15;30(162):210194. doi: 10.1183/16000617.0194-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34911696 Free PMC article. Review.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Soo RA, Han JY, Dafni U, Cho BC, Yeo CM, Nadal E, Carcereny E, de Castro J, Sala MA, Bernabé R, Coate L, Provencio Pulla M, Garcia Campelo R, Cuffe S, Hashemi SMS, Früh M, Massuti B, Garcia-Sanchez J, Dómine M, Majem M, Sanchez-Torres JM, Britschgi C, Pless M, Dimopoulou G, Roschitzki-Voser H, Ruepp B, Rosell R, Stahel RA, Peters S; ETOP 10-16 BOOSTER Collaborators. Soo RA, et al. Among authors: sala ma. Ann Oncol. 2022 Feb;33(2):181-192. doi: 10.1016/j.annonc.2021.11.010. Epub 2021 Nov 26. Ann Oncol. 2022. PMID: 34839016 Free article. Clinical Trial.
miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury.
Yang J, Do-Umehara HC, Zhang Q, Wang H, Hou C, Dong H, Perez EA, Sala MA, Anekalla KR, Walter JM, Liu S, Wunderink RG, Budinger GRS, Liu J. Yang J, et al. Among authors: sala ma. Front Immunol. 2021 Nov 25;12:700933. doi: 10.3389/fimmu.2021.700933. eCollection 2021. Front Immunol. 2021. PMID: 34899681 Free PMC article.
[Informed choice in breast cancer screening: the role of education].
Pons-Rodríguez A, Martínez-Alonso M, Perestelo-Pérez L, Garcia M, Sala M, Rué M; en nombre del grupo InforMa; El grupo InforMa está formado por. Pons-Rodríguez A, et al. Among authors: sala m. Gac Sanit. 2021 May-Jun;35(3):243-249. doi: 10.1016/j.gaceta.2020.01.002. Epub 2020 Mar 12. Gac Sanit. 2021. PMID: 32173050 Free article. Clinical Trial. Spanish.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sàbat M, Abril-Fornaguera J, Akers N, Sala M, Ragull S, Arnal M, Villalmanzo N, Cairo S, Villanueva A, Kappler R, Garrido M, Guerra L, Sábado C, Guillén G, Mallo M, Piñeyro D, Vázquez-Vitali M, Kuchuk O, Mateos ME, Ramírez G, Santamaría ML, Mozo Y, Soriano A, Grotzer M, Branchereau S, de Andoin NG, López-Ibor B, López-Almaraz R, Salinas JA, Torres B, Hernández F, Uriz JJ, Fabre M, Blanco J, Paris C, Bajčiová V, Laureys G, Masnou H, Clos A, Belendez C, Guettier C, Sumoy L, Planas R, Jordà M, Nonell L, Czauderna P, Morland B, Sia D, Losic B, Buendia MA, Sarrias MR, Llovet JM, Armengol C. Carrillo-Reixach J, et al. Among authors: sala m. J Hepatol. 2020 Aug;73(2):328-341. doi: 10.1016/j.jhep.2020.03.025. Epub 2020 Mar 30. J Hepatol. 2020. PMID: 32240714 Free article.
Breast density, benign breast disease, and risk of breast cancer over time.
Román M, Louro J, Posso M, Alcántara R, Peñalva L, Sala M, Del Riego J, Prieto M, Vidal C, Sánchez M, Bargalló X, Tusquets I, Castells X. Román M, et al. Among authors: sala m. Eur Radiol. 2021 Jul;31(7):4839-4847. doi: 10.1007/s00330-020-07490-5. Epub 2021 Jan 6. Eur Radiol. 2021. PMID: 33409776
Antiviral Peptides as Anti-Influenza Agents.
Agamennone M, Fantacuzzi M, Vivenzio G, Scala MC, Campiglia P, Superti F, Sala M. Agamennone M, et al. Among authors: sala m. Int J Mol Sci. 2022 Sep 28;23(19):11433. doi: 10.3390/ijms231911433. Int J Mol Sci. 2022. PMID: 36232735 Free PMC article. Review.
1,135 results